STAND. COM. REP. NO. 133-20
RE: H.B. No. 2676
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirtieth State Legislature
Regular Session of 2020
State of Hawaii
Your Committee on Health, to which was referred H.B. No. 2676 entitled:
"A BILL FOR AN ACT RELATING TO HEALTH CARE,"
begs leave to report as follows:
(1) Require health insurers, mutual benefit societies, and health maintenance organizations to provide coverage for a comprehensive category of reproductive health services, drugs, devices, products, and procedures; and
(2) Prohibit discrimination in the provision of reproductive health services.
Your Committee received testimony in support of this measure from the Hawaii State Commission on the Status of Women; Hawaii Women's Coalition; Hawaii Section of the American College of Obstetricians and Gynecologists; Planned Parenthood Votes Northwest and Hawaii; LGBT Caucus of the Democratic Party of Hawaii; Pride at Work‑Hawaii; AAUW of Hawaii; Midwives Alliance of Hawaii; Breastfeeding Hawaii; WeAreOne, Inc.; Bayer US; ACLU of Hawaii; and numerous individuals. Your Committee received testimony in opposition to this measure from the Hawaii Association of Health Plans. Your Committee received comments on this measure from the Department of Commerce and Consumer Affairs, Hawaii Medical Service Association, Kaiser Permanente Hawaii, and Hawai‘i Primary Care Association.
Your Committee finds that thousands of people in Hawaii lack access to the full range of sexual and reproductive health care services, benefits, and protections. Comprehensive sexual and reproductive health care, without discrimination, is essential for the health and economic security of the people of Hawaii. Your Committee further finds that it is vital to preserve certain important aspects of the federal Patient Protection and Affordable Care Act of 2010 and expand access to comprehensive sexual and reproductive health care for residents of Hawaii.
Your Committee notes that the expansion of coverage for reproductive services proposed by this measure would be a new mandated benefit, and as such, is subject to an impact assessment report by the Auditor pursuant to sections 23-51 and 23-52, Hawaii Revised Statutes.
Your Committee has amended this measure by:
(1) Changing the effective date to July 1, 2050, to encourage further discussion; and
(2) Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2676, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 2676, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.
Respectfully submitted on behalf of the members of the Committee on Health,
JOHN M. MIZUNO, Chair